EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis

Ahmed Elmewafy iD, Eyad Jamileh iD, Abdullah Hussain iD, Loay Kamel iD, Omar Farooq, Hany Gamal, Ibrahim Antoun iD

Cardiovascular Therapeutics · 2026

DOI: 10.1155/cdr/4836688 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cardiovascular Therapeutics, 2026. Verfasst von Ahmed Elmewafy und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Sheffield, Sheffield, UK, sheffield.ac.uk. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Fatty Acid Binding Protein 3. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heart‐type fatty acid‐binding protein (H‐FABP) is rapidly released following myocardial injury, but its prognostic significance in acute coronary syndrome (ACS) remains uncertain. We evaluated the association between elevated H‐FABP and adverse clinical outcomes in confirmed or suspected ACS.

Methods

PubMed, Embase, CENTRAL, Web of Science and Scopus were searched from inception to 30 August 2026 without date restriction. Studies assessing diagnostic and/or prognostic relevance of circulating H‐FABP in adults with confirmed or suspected ACS were eligible. Prognostic outcomes included all‐cause mortality, major adverse cardiovascular events (MACE), heart failure (HF)–related hospitalisation and recurrent myocardial infarction (MI). Risk of bias was assessed using QUIPS. Crude odds ratios (ORs) from extractable 2 × 2 event data were pooled using inverse‐variance random‐effects models with restricted maximum‐likelihood estimation.

Results

Twelve studies were included, with five contributing to meta‐analysis. Elevated H‐FABP was associated with higher odds of all‐cause mortality (OR 5.68; 95% CI 3.98–8.09; I 2 = 30 % ), MACE (OR 4.56; 95% CI 1.97–10.55; I 2 = 47 % ), HF‐related hospitalisation (OR 4.29; 95% CI 2.94–6.26; I 2 = 0 % ) and recurrent MI (OR 1.65; 95% CI 1.15–2.37; I 2 = 0 % ). Pooled estimates were unadjusted; seven studies were synthesised narratively.

Conclusion

Elevated H‐FABP is associated with adverse outcomes in ACS, but current evidence does not establish independent prognostic value. Further prospective studies should determine whether H‐FABP adds predictive value beyond established clinical and biochemical risk markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeFatty Acid Binding Protein 3AgedFemaleHumansMaleMiddle AgedBiomarkersFatty Acid-Binding ProteinsPredictive Value of TestsPrognosisRecurrenceRisk AssessmentRisk FactorsUp-Regulation

Stichwörter der Autor:innen

acute coronary syndromebiomarkersheart-type fatty acid-binding proteinmeta-analysisprognosis

Substanzen

BiomarkersFABP3 protein, humanFatty Acid Binding Protein 3Fatty Acid-Binding Proteins

Autor:innen und Institutionen

  • School of Medicine, University of Sheffield, Sheffield, UK, sheffield.ac.uk.
  • Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, Blackburn, UK, nhs.uk.
  • School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Kingdom of Bahrain, uob.edu.bh.
  • School of Medicine, Royal College of Surgeons of Ireland, University of Medicine and Health Sciences, Dublin, Ireland, rcsi.ie.
  • School of Medicine, St. George's University, St. George's, Grenada.
  • Division of Cardiovascular Sciences, Clinical Science Wing, University of Leicester, Glenfield Hospital, Leicester, UK, nhs.uk.

ORCID-Profile: Ahmed Elmewafy, Eyad Jamileh, Abdullah Hussain, Loay Kamel, Ibrahim Antoun

Zitieren

APA

Elmewafy, A., Jamileh, E., Hussain, A., Kamel, L., Farooq, O., Gamal, H., & Antoun, I. (2026). Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/4836688

Vancouver

Elmewafy A, Jamileh E, Hussain A, Kamel L, Farooq O, Gamal H, et al. Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis. Cardiovascular Therapeutics. 2026. doi:10.1155/cdr/4836688

BibTeX
@article{Elmewafy2026,
  author = {Elmewafy, Ahmed and Jamileh, Eyad and Hussain, Abdullah and Kamel, Loay and Farooq, Omar and Gamal, Hany and Antoun, Ibrahim},
  title = {Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  doi = {10.1155/cdr/4836688}
}
Kostenlos starten →